NDC11 00054027903
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00054-0279-03 | 00054-0279 |
| 00054-0279-3 | 00054-0279 |
| 00054-279-03 | 00054-279 |
| 0054-0279-03 | 0054-0279 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naratriptan | NARATRIPTAN | Hikma Pharmaceuticals USA Inc. | fd1944b3-8054-4faa-a82e-d818dfdd3875 | 2023-03-03 | Warnings, Adverse reactions | 0054-0279-03 0054-0279 00054027903 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.